By Counterforce Health Team in Tagrisso (osimertinib) —

Work With Your Doctor to Get Tagrisso (Osimertinib) Approved by UnitedHealthcare in Florida: Prior Authorization Guide

Answer Box: Getting Tagrisso Approved by UnitedHealthcare in Florida

Tagrisso (osimertinib) requires prior authorization from UnitedHealthcare for all members. To get approved, you need documented EGFR mutation testing (exon 19 deletion or L858R) and your oncologist must submit a complete prior authorization through the UnitedHealthcare Provider Portal. First step today: Call UnitedHealthcare Member Services (number on your insurance card) to confirm Tagrisso's formulary status and copay tier. If denied, you have 180 days for internal appeals, then 4 months for Florida's free external review through the Department of Financial Services.

Table of Contents

  1. Set Your Goal: Understanding UnitedHealthcare's Requirements
  2. Visit Prep: Gathering Your Medical History
  3. Evidence Kit: Essential Documentation
  4. Medical Necessity Letter Structure
  5. Peer-to-Peer Review Support
  6. After-Visit Summary: Tracking Progress
  7. Respectful Persistence: Follow-Up Strategy
  8. Appeals Playbook for Florida Residents
  9. Common Denial Reasons & Solutions
  10. Cost Assistance Options
  11. FAQ

Set Your Goal: Understanding UnitedHealthcare's Requirements

Your partnership with your oncologist is crucial for Tagrisso approval. UnitedHealthcare requires specific clinical criteria that your doctor must document thoroughly.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all members Provider Portal submission UHC PA Requirements
EGFR Mutation Positive exon 19 deletion or L858R FDA-approved testing required UHC Tagrisso Policy
Specialty Pharmacy Optum Specialty mandatory Automatic enrollment after approval OptumRx Requirements
Timeline Up to 15 business days standard 72 hours if expedited UHC Provider Portal

Your role: Come prepared with complete medical history and be available for follow-up questions. Your oncologist handles the technical submission, but your preparation makes their job easier and improves approval chances.

Visit Prep: Gathering Your Medical History

Before your appointment, create a comprehensive timeline that addresses UnitedHealthcare's specific criteria.

Essential Information to Organize

Diagnosis Details:

  • Exact NSCLC staging (IB-IIIB for adjuvant, advanced/metastatic for treatment)
  • Date of initial diagnosis
  • EGFR mutation test results with methodology and date

Treatment History:

  • All prior therapies tried, with dates and outcomes
  • Reasons for discontinuation (progression, toxicity, intolerance)
  • Current performance status and symptoms

Clinical Setting:

  • Adjuvant (post-surgical with prior chemotherapy)
  • Locally advanced/unresectable
  • Recurrent, advanced, or metastatic disease
Tip: Write down specific side effects from previous treatments. UnitedHealthcare considers documented intolerance when approving non-preferred therapies.

Evidence Kit: Essential Documentation

Your oncologist needs comprehensive evidence to support medical necessity. Help them gather:

Required Clinical Documentation

Laboratory Reports:

  • EGFR mutation testing from FDA-approved methodology
  • Complete pathology report confirming NSCLC
  • Recent imaging showing disease status

Medical History Summary:

  • Chronological treatment timeline
  • Documentation of treatment failures or contraindications
  • Current medication list (checking for drug interactions)

Supporting Guidelines:

  • NCCN guideline references for your specific clinical scenario
  • FDA labeling for approved indications

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to identify the specific denial basis and draft point-by-point rebuttals aligned to each plan's requirements.

Medical Necessity Letter Structure

Your oncologist's letter of medical necessity should address UnitedHealthcare's specific coverage criteria systematically.

Key Components for Success

Patient Summary Section:

  • Demographics and insurance information
  • Precise NSCLC diagnosis with staging
  • EGFR mutation status with test details
  • Current clinical scenario (adjuvant vs. metastatic)

Medical Necessity Justification:

  • FDA-approved indication alignment
  • NCCN guideline category (1, 2A, or 2B preferred)
  • Prior therapy outcomes and rationale for Tagrisso
  • Contraindications to alternative treatments

Supporting Evidence:

  • Attached EGFR test results
  • Imaging reports showing disease status
  • Prior treatment summary with outcomes
  • Relevant published literature for off-label use
From our advocates: We've seen the strongest approvals when letters directly quote UnitedHealthcare's own policy language and map each clinical fact to specific coverage criteria. This approach demonstrates clear alignment with plan requirements.

Peer-to-Peer Review Support

If initial authorization is denied, your oncologist may request a peer-to-peer review with a UnitedHealthcare clinical reviewer.

How to Support Your Doctor

Schedule Flexibility:

  • Provide your availability for urgent decisions
  • Be prepared for questions about symptom progression
  • Have recent imaging or lab results accessible

Case Summary Preparation:

  • One-page timeline of treatments and outcomes
  • Clear statement of why alternatives aren't appropriate
  • NCCN guideline references with specific categories

Contact Information:

  • UnitedHealthcare Provider Services: 1-877-842-3210
  • Peer-to-peer requests coordinated through Provider Portal

After-Visit Summary: Tracking Progress

Stay organized and informed throughout the authorization process.

What to Save and Track

Documentation to Keep:

  • Copy of prior authorization submission
  • All correspondence with UnitedHealthcare
  • Denial letters with specific reasons
  • Appeal submission confirmations

Portal Access:

  • Request access to your provider's portal updates
  • Monitor authorization status regularly
  • Save screenshots of important communications

Timeline Tracking:

  • Submission date
  • Expected decision date (15 business days standard)
  • Appeal deadlines if denied

Respectful Persistence: Follow-Up Strategy

Maintain appropriate follow-up without overwhelming your healthcare team.

Week 1-2: Allow normal processing time Week 3: Check status via provider portal or call After denial: Immediate appeal planning within 180-day deadline During appeals: Weekly status checks

Escalation Guidelines

Contact UnitedHealthcare Member Services if:

  • No response after 15 business days
  • Missing required documentation identified
  • Appeal deadlines approaching

Appeals Playbook for Florida Residents

Florida residents have specific rights and timelines for challenging UnitedHealthcare denials.

Step-by-Step Appeals Process

Level 1: Internal Appeal

  • Deadline: 180 days from denial notice
  • Timeline: 30 days standard, 72 hours expedited
  • Submission: UnitedHealthcare Provider Portal or member services
  • Required: Denial letter, medical records, physician appeal letter

Level 2: External Review (Florida DFS)

  • Deadline: 4 months after final internal denial
  • Timeline: 45 days standard, 72 hours expedited
  • Cost: Free to consumers
  • Contact: Florida DFS at (800) 342-2762
  • Decision: Binding on UnitedHealthcare

Required Documentation for Appeals

  • Original denial letter with specific reasons
  • Updated medical records addressing denial concerns
  • Physician letter explaining medical necessity
  • NCCN guideline references supporting treatment
  • Evidence of prior treatment failures or contraindications

For complex appeals involving specialty drugs like Tagrisso, Counterforce Health can help identify the denial basis and draft targeted rebuttals that align with UnitedHealthcare's specific policy requirements.

Common Denial Reasons & Solutions

Denial Reason Documentation Needed Appeal Strategy
No EGFR mutation documented FDA-approved test results Submit complete pathology report with methodology
Wrong clinical setting Staging and treatment history Clarify adjuvant vs. metastatic indication
Step therapy not completed Prior treatment records Document failures, intolerances, or contraindications
Quantity limits exceeded Dosing rationale Provide clinical justification for prescribed dose
Not medically necessary Clinical guidelines Reference NCCN categories and FDA labeling

Cost Assistance Options

Even with UnitedHealthcare coverage, Tagrisso costs can be significant.

Available Support Programs

AstraZeneca Patient Assistance:

  • AZ&Me Prescription Savings Program
  • Eligibility based on income and insurance status
  • Apply at AZandMe.com

Copay Assistance:

  • Commercial insurance members may qualify for $0 copay
  • Not available for government insurance (Medicare, Medicaid)

Foundation Grants:

  • Patient Advocate Foundation
  • Good Days Foundation
  • CancerCare Co-Payment Assistance

FAQ

How long does UnitedHealthcare prior authorization take in Florida? Standard review takes up to 15 business days. Expedited review for urgent cases is completed within 72 hours when disease progression threatens patient health.

What if Tagrisso is non-formulary on my plan? Non-formulary drugs can still be covered with prior authorization and medical necessity documentation. Your oncologist must demonstrate why formulary alternatives are inappropriate.

Can I request an expedited appeal in Florida? Yes, if delay would seriously jeopardize your health. Your physician must provide documentation supporting the urgent need for expedited review.

Does step therapy apply if I failed treatments outside Florida? Florida law requires insurers to accept documented treatment failures from out-of-state providers, provided medical records are complete and verifiable.

What happens if UnitedHealthcare denies my external review? External review decisions in Florida are binding on insurers. If approved, UnitedHealthcare must cover the treatment. If denied, you may have additional options through state consumer protection agencies.

How do I check my formulary tier for Tagrisso? Call UnitedHealthcare Member Services (number on your insurance card) or check your plan's formulary document, typically available on the member portal.

Can my doctor prescribe generic osimertinib? Tagrisso is still under patent protection. Generic versions are not yet available in the United States.

What if I miss an appeal deadline? Contact Florida DFS immediately at (800) 342-2762. They may be able to help if the insurer provided inadequate notice or instructions.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance company for guidance specific to your situation. Coverage policies and appeal processes may vary by plan type and can change. Verify current requirements with official sources before making healthcare decisions.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.